ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
VIENNA, Feb. 21, 2024 /PRNewswire/ -- ScreenPoint Medical is showcasing its industry leading Transpara Breast AI at the 2024 European Congress of Radiology (ECR) meeting, February 28-March 3, 2024 (Booth #AI-31 in Expo Hall X1). Transpara provides radiologists with a 'second pair' of eyes to help detect cancers earlier and reduce recall rates.
- Transpara continues to deliver proven clinical and workflow benefits in mammography screening in global practice and clinical research.
- AI-supported screening resulted in significant and substantial improvements compared to double reading without AI.
- This presentation can be seen is: "Is it worth reading low-risk breast cancer screening mammograms as determined by an artificial intelligence (AI) system?
- An informed review of 120 interval cancer cases with high AI scores in breast screen Norway (RPS-2405, ACV Research Stage 1, March 3, 11.30am).